ECCO News

ECCO News keeps ECCO Members up-to-date on what is going on within the organisation and reports on IBD activities taking place within Europe. Since Spring 2006, ECCO News has maintained the flow of information between Members of the organisation. 

ECCO News is an important part of the European Crohn’s and Colitis Organisation’s ambition to create a European standard of IBD care and to promote knowledge and research in the field of IBD. ECCO Members automatically receive this publication four times a year. 

Editor


Alessandro Armuzzi
© ECCO

Associate Editors


Nuha Yassin
© ECCO

Ignacio Catalán-Serra
© Ignacio Catalán-Serra

Latest ECCO News Content


17September2021

Report on the 1st ECCO Postgraduate Course, Virtual

Henit Yanai, EduCom Chair and Pascal Juillerat, e-Learning Ambassador

Henit Yanai
© ECCO


Pascal Juillerat

© ECCO

The ECCO Postgraduate Course (PGC) in IBD is underway! While the 1st ECCO PGC was by necessity virtual, there is no doubt that we made history. Two hundred and forty participants registered from within and beyond Europe in order to gain intensive education in Inflammatory Bowel Diseases (IBD).

Posted in ECCO News, Committee News, EduCom, Volume 16, Issue 3, ECCO'21

17September2021

Report on the 19th ECCO IBD Intensive Course for Trainees, Virtual 2021

Kostas Karmiris, EduCom Member

 


Kostas Karmiris
© ECCO

The 19th IBD Intensive Course for Trainees was held virtually on July 2, one week before the ECCO Congress, as part of the educational programme.

This oldest and most established course took place once again this year, although in a virtual design, and was attended by a total of 100 physicians from 33 countries from Europe and elsewhere. The course offered a comprehensive update on IBD and provided pivotal insights into the medical management for IBD patients in an interactive manner.

Posted in ECCO News, Committee News, Congress News, EduCom, Volume 16, Issue 3, ECCO'21

17September2021

Reports on the 3rd ECCO Basic Imaging Workshop in collaboration with ESGAR: Ultrasound/MRI and the 8th ECCO Ultrasound Workshop – Advanced

Christian Maaser, EduCom Member

 


Christian Maaser
© ECCO

The hands-on imaging workshops have become one of the most rapidly booked ECCO Workshops in recent years as they are known to offer excellent interactivity. Participants have the opportunity to explore the potential of intestinal ultrasound (IUS) through the use of hands-on simulators and in some years even by imaging patients. In addition, there is always very interactive discussion in small groups with radiologists who are internationally well known for their expertise in abdominal imaging.

Posted in ECCO News, Committee News, Congress News, EduCom, Volume 16, Issue 3, ECCO'21

17September2021

Report on the 3rd ECCO Basic Imaging Workshop in collaboration with ESGAR: Endoscopy

Marietta Iacucci, EduCom Member

 


Marietta Iacucci
© ECCO

In 2021 the ECCO Endoscopy Workshop reached its 7th edition, and it has now become a mainstay of the educational activities of ECCO. This year it moved online as a fully virtual meeting and was organised by the Education Committee (EduCom).

Participating speakers and chairs: Ralf Bisschops, Belgium; Bu'Hussain Hayee, UK; Rosanna Cannatelli, Italy; Marietta Iacucci, UK, Pierre Ellul, Malta

Posted in ECCO News, Committee News, Congress News, EduCom, Volume 16, Issue 3, ECCO'21

17September2021

A letter from the e-Learning Ambassador

Pascal Juillerat, e-Learning Ambassador

Pascal Juillerat 
© ECCO

Dear ECCO Members,

I truly hope that you and your loved ones are faring well and that you enjoyed well-deserved rest during the summer.

I also hope that you all enjoyed the exciting scientific and educational programmes at ECCO’21 Congress in July. All of the presentations of both programmes are available on demand on the virtual congress platform until October 31, 2021. This was the first time that ECCO held its Congress virtually – the preparations kept everyone at ECCO very occupied with the organisation having been just as tough and demanding as for a physical congress. By no means did this signify that the production of our e-Learning material had been hampered – on the contrary, we have prepared plenty of new material for you to check out, and made significant improvements to the IBD Curriculum!

To make it easier to navigate and learn from, the IBD Curriculum now directly links to material in the e-library. This provides a more wholesome and hands-on overview for those seeking to develop their expertise in IBD.!

Posted in ECCO News, EduCom, Volume 16, Issue 3

17September2021

Best epidemiological abstracts at ECCO’21

Valerie Pittet & Julien Kirchgesner, EpiCom Members

Valerie Pittet
© ECCO


Julien Kirchgesner
© ECCO

A total of 76 abstracts focussing on IBD epidemiology were accepted for presentation at the 16th Congress of ECCO. Among the ten best abstracts, one was presented in the scientific programme and nine in digital oral presentation (DOP) sessions. The remaining 66 abstracts were presented as posters.

Posted in ECCO News, Committee News, Volume 16, Issue 3, ECCO'21, EpiCom

17September2021

National Study Group Interview with Henit Yanai

Uri Kopylov, ClinCom Member

Take your study to the next level with the IBD National Study Group Meeting at the ECCO Congress


Uri Kopylov 
© ECCO

One of the missions of the Clinical Research Committee of ECCO (ClinCom) is to facilitate innovative clinical research in the area of Inflammatory Bowel Diseases (IBD).

To promote international scientific collaboration among researchers from different European countries, ClinCom established the IBD National Study Group Meeting, which takes place at the annual ECCO Congress. With this great platform, ClinCom enables investigators to have their studies challenged and promoted at the same time. Before the meeting, investigators are invited to provide a study synopsis for their project, including background, design, objectives, outcome parameters, major inclusion and exclusion criteria, statistics and co-variates. Submitted projects are then reviewed by ClinCom and, if found feasible, discussed during the IBD National Study Group Meeting at the ECCO Congress.

Posted in ECCO News, Committee News, Congress News, ClinCom, ECCO'22, Volume 16, Issue 3

17September2021

Report from IIS Award Winner 2021: Nicolas Pierre

Nicolas Pierre, ECCO Member


Nicolas Pierre
© Nicolas Pierre

Blood proteins related to immunoregulation or cellular junctions reveal distinct biological profiles associated with the risk of short-term versus mid/long-term relapse in Crohn’s Disease patients stopping infliximab

In Crohn’s Disease (CD), anti-tumour necrosis factor α (TNFα) therapy can induce mucosal healing and stable remission. When this objective is achieved, treatment de-escalation may be considered for safety, economic and patient preference purposes. Indeed, chronic exposure to anti-TNFα has been linked to serious complications (e.g. lymphoma, infections, melanoma and non-melanoma skin cancers) [1–4], and this treatment is a burden for the healthcare system [5]. On the other hand, around 50% of CD patients relapse 1–2 years after stopping anti-TNFα [6]. Thus, this strategy cannot be proposed to every patient in remission; rather, decisions should be made on an individualised basis [6].

Posted in ECCO News, Committee News, ClinCom, Volume 16, Issue 3, ECCO'21

17September2021

Report on the 5th Advanced ECCO: EduCational COurse for Industry

Shaji Sebastian, ClinCom Member


Shaji Sebastian
© ECCO

The 5th Advanced ECCO: EduCational COurse for Industry, organised by the Clinical Research Committee of ECCO (ClinCom), was one of the highlights of the educational programme during the ECCO’21 Congress and was held virtually, with live presentations and discussions. The course was aimed at our industry partners and had the broad goal of discussing the areas of IBD research of key importance in the immediate future. 

Posted in ECCO News, Committee News, Congress News, ClinCom, Volume 16, Issue 3, ECCO'21

17September2021

Report on the 4th School for Clinical Trialists at ECCO'21

Laurent Beaugerie, ClinCom Member

Laurent Beaugerie
© ECCO

This year’s 4th School for Clinical Trialists, organised by the ECCO Clinical Research Committee (ClinCom), offered an excellent opportunity to review all the key points of the balance between expected efficacy and potential risks of IBD drugs, in the contexts of both clinical trials and routine care.

Posted in ECCO News, Committee News, ClinCom, Volume 16, Issue 3, ECCO'21

Portal